CRVO Financials | Income, Balance Sheet & Cash Flow
The financial statements for CRVO (CRVO) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| OSTX OS Therapies Incorporated | $1.39 +5.30% |
| NTRB Nutriband Inc. | $4.06 +2.01% |
| FBIO Fortress Biotech, Inc. | $2.42 +0.00% |
| R Ryder System, Inc. | $219.83 -0.34% |
| ADAG Adagene Inc. | $3.81 -0.78% |
| NRXP NRx Pharmaceuticals, Inc. | $2.50 +9.65% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| OSTX OS Therapies Incorporated | $1.39 | +5.30% | 56.24 M | -1.42 | -0.98 | 0.00% | Buy | 632 |
| NTRB Nutriband Inc. | $4.06 | +2.01% | 49.43 M | -1.33 | -3.05 | 0.00% | Buy | 5 |
| FBIO Fortress Biotech, Inc. | $2.42 | +0.00% | 77.93 M | -34.57 | -0.07 | 0.00% | Buy | 244 |
| R Ryder System, Inc. | $219.83 | -0.34% | 8.67 B | 18.32 | 12.00 | 1.61% | Buy | 255 |
| ADAG Adagene Inc. | $3.81 | -0.78% | 143.44 M | -10.03 | -0.38 | 0.00% | Buy | 250 |
| NRXP NRx Pharmaceuticals, Inc. | $2.50 | +9.65% | 43.21 M | -1.87 | -1.34 | 0.00% | Buy | 1.59 |
Frequently Asked Questions
What are CRVO's latest financial results?
Review CRVO's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has CRVO's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is CRVO's cash flow situation and liquidity?
Cash flow statements reveal how CRVO generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does CRVO's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether CRVO is outperforming or lagging within its sector.
Are CRVO's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether CRVO's profits are repeatable and supported by strong fundamentals.